DISRUPTIONS IN LIPID METABOLISM AND THE RESULTING DISEASES
Keywords:
Keywords: Lipid Metabolism, Dyslipidemia, Hyperlipidemia, Atherosclerosis, Obesity, Type 2 Diabetes, Cardiovascular Disease, Metabolic Syndrome, Triglycerides, CholesterolAbstract
Abstract
Lipid metabolism plays a crucial role in maintaining cellular structure and
function, energy storage, and hormone production. Disruptions in lipid metabolism can
lead to a variety of disorders, including dyslipidemia, obesity, and cardiovascular
diseases. Dyslipidemia, which includes conditions such as hypercholesterolemia and
hypertriglyceridemia, is a major risk factor for atherosclerosis and other metabolic
diseases. This article explores the mechanisms of lipid metabolism, the
pathophysiology of metabolic disruptions, and the diseases associated with these
disruptions.
References
References
1. Ginsberg, H. N., & Zhang, Y. (2017). "Dyslipidemia and Cardiovascular Disease:
Mechanisms and Management." The Journal of Clinical Lipidology, 11(5), 968-
974. https://doi.org/10.1016/j.jacl.2017.06.014
2. Sacks, F. M., & Tonelli, M. (2009). "Management of Dyslipidemia and
Cardiovascular Risk." The New England Journal of Medicine, 361(7), 747-757.
https://doi.org/10.1056/NEJMra0906168
3. Alberti, K. G., Zimmet, P., & Shaw, J. (2005). "Metabolic Syndrome—a New
World-Wide Definition." A Consensus Statement from the International Diabetes
Federation. Diabetic Medicine, 23(5), 469-480. https://doi.org/10.1111/j.1464-
5491.2005.01658.x
4. Muntner, P., & He, J. (2009). "Obesity and Cardiovascular Disease: Risk Factors
and Mechanisms." Current Opinion in Lipidology, 20(6), 521-527.
https://doi.org/10.1097/MOL.0b013e32833255b9
5. Toth, P. P. (2016). "Non-Alcoholic Fatty Liver Disease (NAFLD): A
Comprehensive Overview of Treatment Options." Journal of Clinical Lipidology,
10(3), 601-609. https://doi.org/10.1016/j.jacl.2016.01.003
